Amarantus Bioscience Holdings Inc (AMBS)

[zoomboom]

this below is from ZACK's report from MAY 2013, but keep in mind the $4 Million from the raise and the $20 Million line from LPC may accelerate all of this if it has not already

the company plans to initiate MANF toxicology studies upon development of a master cell bank of MANF protein material as one of the final pre-IND step. The state goal is to file the investigation new drug (IND) application before the end of the year 2014.

http://scr.zacks.com/files/doc_coverage/Biotech%20-%20Jason%20Napodano/AMBS/May%2022%202013_AMBS_Napodano_v001_g2394h.pdf